Physician profile
Jeff D Almand
NPI 1548217904
$108,584.78
in general payments reported to CMS, 2019-2025
14 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,054 · 2020: $18K · 2021: $57K · 2022: $14K · 2023: $11K · 2024: $564 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,525 · Travel and Lodging: $1,350 · Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,525.00 |
| Travel and Lodging | $1,350.47 |
| Food and Beverage | $973.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $101,794.55 | 2019-2025 | Rosa, Persona |
| Medical Device Business Services, INC. | $5,519.58 | 2019 | |
| Depuy Synthes Sales INC. | $300.07 | 2019-2025 | Attune |
| Pacira Therapeutics, INC. | $215.02 | 2019-2020 | |
| Brainlab, INC. | $213.00 | 2019 | |
| Medacta USA, INC. | $139.76 | 2025 | Gmk Sphere |
| Alon Medical Technology | $139.06 | 2022 | |
| Boston Scientific Corporation | $122.21 | 2021 | |
| Eagle Pharmaceuticals, INC. | $49.42 | 2023 | |
| Orthalign INC | $27.29 | 2024 | Orthalign Plus |
| Pacira Pharmaceuticals Incorporated | $22.66 | 2022 | |
| Bioventus LLC | $14.82 | 2024 | Durolane |
| Inari Medical, INC. | $14.37 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ferring Pharmaceuticals INC. | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Almand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.